These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 32788113)
1. Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in patients with venous thromboembolism treated with vitamin K antagonists: Findings from the RIETE registry. Del-Toro-Cervera J; Demelo-Rodriguez P; Galeano-Valle F; Fidalgo Á; Sampériz Á; Muñoz-Torrero JFS; Lima J; Sigüenza P; Tufano A; Monreal M; Thromb Res; 2020 Oct; 194():178-182. PubMed ID: 32788113 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in a cohort of patients with venous thromboembolism treated with vitamin K antagonists. Demelo-Rodríguez P; Postigo-Esteban A; García-Fernández-Bravo I; Agud M; Calpena S; Camacho M; Del Toro-Cervera J Thromb Res; 2016 Nov; 147():58-60. PubMed ID: 27676254 [TBL] [Abstract][Full Text] [Related]
3. The SAME-TT2R2 score predicts the quality of anticoagulation control in patients with acute VTE. A real-life inception cohort study. Palareti G; Antonucci E; Lip GY; Testa S; Guazzaloca G; Falanga A; Pengo V; Poli D; Thromb Haemost; 2016 Jun; 115(6):1101-8. PubMed ID: 26819229 [TBL] [Abstract][Full Text] [Related]
4. Quality of oral anticoagulation with vitamin K antagonists in 'real-world' patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry. Esteve-Pastor MA; Rivera-Caravaca JM; Roldán-Rabadán I; Roldán V; Muñiz J; Raña-Míguez P; Ruiz-Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Anguita M; Lip GYH; Marín F; Europace; 2018 Sep; 20(9):1435-1441. PubMed ID: 29095971 [TBL] [Abstract][Full Text] [Related]
5. Use of SAMe-TT Wang K; Lu Y; Simegn MA; Xue H; Asinger RW J Thromb Thrombolysis; 2023 Jan; 55(1):175-180. PubMed ID: 36352057 [TBL] [Abstract][Full Text] [Related]
6. Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists. Ruiz-Ortiz M; Bertomeu V; Cequier Á; Marín F; Anguita M Thromb Haemost; 2015 Oct; 114(4):695-701. PubMed ID: 26054407 [TBL] [Abstract][Full Text] [Related]
7. Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trials. Proietti M; Lane DA; Lip GY Int J Cardiol; 2016 Aug; 216():168-72. PubMed ID: 27156060 [TBL] [Abstract][Full Text] [Related]
8. Use of the SAMe-TT Zulkifly H; Lip GYH; Lane DA Heart Rhythm; 2018 Apr; 15(4):615-623. PubMed ID: 29180122 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the mean time in the therapeutic INR range and the SAME-TT2R2 score in patients with atrial fibrillation and cognitive impairment. Gorzelak-Pabiś P; Zyzak S; Krewko Ł; Broncel M Pol Arch Med Wewn; 2016 Aug; 126(7-8):494-501. PubMed ID: 27511466 [TBL] [Abstract][Full Text] [Related]
10. The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study. Roldán V; Cancio S; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY Am J Med; 2015 Nov; 128(11):1237-43. PubMed ID: 26087049 [TBL] [Abstract][Full Text] [Related]
11. Usefulness of the SAME-TT2R2 score to predict anticoagulation control on VKA in patients with atrial fibrillation and obstructive sleep apnea. Szymanski FM; Lip GY; Filipiak KJ; Platek AE; Karpinski G Int J Cardiol; 2016 Feb; 204():200-5. PubMed ID: 26670173 [TBL] [Abstract][Full Text] [Related]
12. SAMe-TT2R2 Score in the Outpatient Anticoagulation Clinic to Predict Time in Therapeutic Range and Adverse Events. Pivatto Junior F; Scheffel RS; Ries L; Wolkind RR; Marobin R; Barkan SS; Amon LC; Biolo A Arq Bras Cardiol; 2017 Apr; 108(4):290-296. PubMed ID: 28538758 [TBL] [Abstract][Full Text] [Related]
14. SAMe-TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation. Gallego P; Roldán V; Marin F; Gálvez J; Valdés M; Vicente V; Lip GYH Am J Med; 2014 Nov; 127(11):1083-1088. PubMed ID: 24858062 [TBL] [Abstract][Full Text] [Related]
15. Assessment of the Quality of Chronic Anticoagulation Control With Time in Therapeutic Range in Atrial Fibrillation Patients Treated With Vitamin K Antagonists by Hemostasis Specialists: The TERRA Registry: Tiempo en rango en la República Argentina. Tajer C; Ceresetto J; Bottaro FJ; Martí A; Casey M; Clin Appl Thromb Hemost; 2017 Jul; 23(5):445-453. PubMed ID: 26739542 [TBL] [Abstract][Full Text] [Related]
16. The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation. Esteve-Pastor MA; Roldán V; Valdés M; Lip GY; Marín F Expert Rev Cardiovasc Ther; 2016; 14(2):177-87. PubMed ID: 26559964 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of SAMe-TT2R2 risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists. Abumuaileq RR; Abu-Assi E; Raposeiras-Roubin S; López-López A; Redondo-Diéguez A; Álvarez-Iglesias D; Rodríguez-Mañero M; Peña-Gil C; González-Juanatey JR Europace; 2015 May; 17(5):711-7. PubMed ID: 25662984 [TBL] [Abstract][Full Text] [Related]
18. SAMe-TT Incomenoy S; Saokaew S; Poonchuay N Ann Pharmacother; 2024 Feb; 58(2):126-139. PubMed ID: 37125752 [TBL] [Abstract][Full Text] [Related]
19. Prediction Score for Anticoagulation Control Quality Among Older Adults. Lin KJ; Singer DE; Glynn RJ; Blackley S; Zhou L; Liu J; Dube G; Oertel LB; Schneeweiss S J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982676 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Validity of SAMe-TT Alhmoud EN; Elewa H; Abdul Gelil MS; Abd El Samad OB; Elzouki AY Clin Appl Thromb Hemost; 2020; 26():1076029620945039. PubMed ID: 32875827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]